Santen Pharmaceutical Co Ltd (4536) - Medical Equipment - Deals and Alliances Profile
October 2018
43
About the Report
About the Report
Summary
Santen Pharmaceutical Co Ltd (Santen) focuses on the research, development, manufacture and marketing of pharmaceutical products and medical devices. Its product portfolio includes prescription ophthalmic products for bacterial conjunctivitis, glaucoma, dry eye, Inflammation and others; OTC ophthalmic products; anti-allergy ophthalmic products; and medical devices such as intraocular lenses (IOLs) and others. Some of its major brands include Livostin, Alesion, Tarivid, Cosopt, Tapros, Cravit, Diquas Hyalein and others. Santen operates through group companies in Asia, Europe and the US. The company's R&D activities focus on the development of ophthalmic treatments. Santen is headquartered in Kita-ku, Osaka, Japan.
Santen Pharmaceutical Co Ltd (4536)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Santen Pharmaceutical Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Santen Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Santen Pharmaceutical Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Santen Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Santen Pharmaceutical Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Santen Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Santen Pharmaceutical Co Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
InnFocus Raises Additional USD1 Million in Series C Financing 10
InnFocus Raises USD32.8 Million in Series C Financing Round 11
Clearside Biomedical Raises USD16 Million in Series B Venture Financing 12
InnFocus Raises USD 13.5 Million In Series B Financing 14
Clearside Biomedical Raises USD 8 Million In Venture Financing 15
Partnerships 17
Santen Pharma Enters into Licensing Agreement with STAAR Surgical 17
Durect Enters into Licensing Agreement with Santen Pharma 18
Sharp Enters into Agreement with Santen Pharma 19
Debt Offering 20
International Biomedical Devices Raises USD2.3 Million in Private Placement of Notes 20
Acquisition 21
Santen Pharma Acquires InnFocus 21
Santen Pharmaceutical Co Ltd-Key Competitors 22
Santen Pharmaceutical Co Ltd-Key Employees 23
Santen Pharmaceutical Co Ltd-Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 28
Financial Announcements 28
May 09, 2018: Santen Reports Fiscal 2017 Consolidated Performance 28
Nov 01, 2017: Santen Consolidated Results for Q2 Fiscal 2017 29
Aug 01, 2017: Santen Pharma Reports Revenue Of JPY55.95 Billion In Q1 Fiscal 2018 30
May 10, 2017: Santen Reports Fiscal 2016 Consolidated Performance 31
Feb 07, 2017: Santen Pharma Reports Revenue Of JPY150.7 Billion In Nine Months Ended December 31, 2016 32
Corporate Communications 33
Sep 12, 2018: Santen Pharmaceutical announce personnel changes of representative Director of the Board 33
Jul 17, 2018: Santen Donates to Japan Flood and Landslide Relief Efforts 34
Mar 01, 2018: Luis Iglesias Promoted to Head of Santen EMEA 35
Feb 20, 2018: Santen Announces Appointment of New President 36
Jul 18, 2017: Santen Donates to Northern Kyushu Area Disaster Relief Efforts 37
May 10, 2017: Santen: Notice of Board of Director and Corporate Auditor Nominations 38
Mar 15, 2017: Santen Pharmaceutical: Notice of Corporate Officer Appointments 40
Other Significant Developments 42
Jun 04, 2018: Santen Announces Medium-Term Plan (MTP2020) 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43
List of Figure
List of Figures
Santen Pharmaceutical Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Santen Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Santen Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Santen Pharmaceutical Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Santen Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Santen Pharmaceutical Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Santen Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Santen Pharmaceutical Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List of Table
List of Tables
Santen Pharmaceutical Co Ltd, Medical Equipment, Key Facts, 2018 2
Santen Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Santen Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Santen Pharmaceutical Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Santen Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Santen Pharmaceutical Co Ltd, Deals By Market, 2012 to YTD 2018 8
Santen Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
InnFocus Raises Additional USD1 Million in Series C Financing 10
InnFocus Raises USD32.8 Million in Series C Financing Round 11
Clearside Biomedical Raises USD16 Million in Series B Venture Financing 12
InnFocus Raises USD 13.5 Million In Series B Financing 14
Clearside Biomedical Raises USD 8 Million In Venture Financing 15
Santen Pharma Enters into Licensing Agreement with STAAR Surgical 17
Durect Enters into Licensing Agreement with Santen Pharma 18
Sharp Enters into Agreement with Santen Pharma 19
International Biomedical Devices Raises USD2.3 Million in Private Placement of Notes 20
Santen Pharma Acquires InnFocus 21
Santen Pharmaceutical Co Ltd, Key Competitors 22
Santen Pharmaceutical Co Ltd, Key Employees 23
Santen Pharmaceutical Co Ltd, Other Locations 25
Santen Pharmaceutical Co Ltd, Subsidiaries 26
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.